Study to Assess the Effect of Meplazumab on COVID-19
Clinical trial NCT04586153 · COMPLETED
Trial details
- NCT number
- NCT04586153
- Sponsor
- Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-15
- Primary completion
- 2022-12-02
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.